AstraZeneca PLC/ GB0009895292 /
2024-03-18 5:29:49 PM | Chg. +10.00 | Volume | Bid5:29:49 PM | Ask5:29:49 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1,380.50SEK | +0.73% | 179,321 Turnover: 245.33 mill. |
1,379.50Bid Size: 622 | 1,380.00Ask Size: 50 | 2120.5 bill.SEK | - | - |
GlobeNewswire
02-26
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire
02-05
Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, an...
GlobeNewswire
02-02
BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis in Japanese Patie...
GlobeNewswire
01-16
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Bioph...
GlobeNewswire
01-08
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Bioph...
GlobeNewswire
01-04
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, I...
GlobeNewswire
01-04
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, I...